The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

Even so, broadening the range of trials’ participants can be practically useful, because they may lead to new medical ...

Moderna is betting on mRNA technology to do just that. To Fink’s knowledge, none of its competitors has made it to Phase 3 of a clinical trial involving an mRNA norovirus vaccine. The goal of ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...

Analyst Mani Foroohar of Leerink Partners maintained a Sell rating on Moderna (MRNA – Research Report), reducing the price target to ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...